Showing results (131-140 of 192) with videos related to
Sort By:
Pageof 20
Circulation Research|March 22, 2000
Hypercholesterolemia causes mechanical weakening of rabbit atheroma : local collagen loss as a prerequisite of plaque ruptureM D Rekhter, G W Hicks, D W Brammer, et al.The American Journal of Gastroenterology|October 29, 2000
Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment GroupM L Shiffman, C M Hofmann, J Gabbay, et al.Journal of Medicinal Chemistry|April 28, 1995
Evaluation of physicochemical parameters important to the oral bioavailability of peptide-like compounds: implications for the synthesis of renin inhibitorsH W Hamilton, B A Steinbaugh, B H Stewart, et al.Journal of Medicinal Chemistry|January 1, 1992
Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitorsA M Doherty, I Sircar, B E Kornberg, et al.Gut|December 20, 2003
Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naïve patients with chronic hepatitis CP J Thuluvath, A Maheshwari, J Mehdi, et al.Journal of Medicinal Chemistry|July 20, 1992
Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitorsW C Patt, H W Hamilton, M D Taylor, et al.The Journal of Biological Chemistry|July 10, 1979
Total synthesis of a tyrosine suppressor transfer RNA gene. XVI. Enzymatic joinings to form the total 207-base pair-long DNAT Sekiya, T Takeya, E L Brown, et al.Journal of Medicinal Chemistry|March 1, 1991
N6-substituted adenosine receptor agonists: potential antihypertensive agentsB K Trivedi, C J Blankley, J A Bristol, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacologyM J Ryan, F A Bjork, D M Cohen, et al.The Journal of Pharmacology and Experimental Therapeutics|February 1, 1984
Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitorM J Ryan, D M Boucher, D M Cohen, et al.Pageof 20